Skip to content Skip to navigation

Otomycosis in immunocompetent and immunocompromised patients: Comparative study and literature review

| Reprints
March 1, 2012
by Borlingegowda Viswanatha, MS, DLO, Dadarao Sumatha, MBBS, and Maliyappanahalli Siddappa Vijayashree, MBBS, MS


A comparative clinical study was carried out that included 50 cases of otomycosis in immunocompetent patients and 50 cases of otomycosis in immunocompromised patients. Clinical presentation, predisposing factors, mycologic profile, and treatment outcomes were compared. Aspergillus spp were the most commonly isolated fungi in the immunocompetent group, and Candida albicans in the immunocompromised group. Bilateral involvement was more common in the immunocompromised group. All the patients were treated with topical clotrimazole ear drops. Four patients in the immunocompromised group did not respond to treatment with clotrimazole but were treated successfully with fluconazole ear drops. Three patients had a small tympanic membrane perforation due to otomycosis.

ENT Journal provides full text articles to our registered members.
Please log in or sign up for a FREE membership to view the full content:

You may also like to: